Literature DB >> 6170323

Binding, surface mobility, internalization, and degradation of rhodamine-labeled alpha 2-macroglobulin.

F R Maxfield, M C Willingham, H T Haigler, P Dragsten, I H Pastan.   

Abstract

We have used quantitative fluorescence methods to examine the fate of rhodamine-labeled alpha 2-macroglobulin (R-alpha 2 M) after binding to cell-surface receptors on NRK and Swiss 3T3 cells. From measurements of fluorescence intensities in NRK cells fixed after incubation with R-alpha 2M, we found that uptake was saturable and that half-maximal uptake occurred at 130 nM R-alpha 2M. Fluorescence measurements on cell extracts of NRK and Swiss 3T3 cells also showed a half-maximal uptake of R-alpha 2M near 130 nM. We estimate that NRK cells can take up 10(6) molecules of R-alpha 2M per hour via receptor-mediated endocytosis. The mobility of alpha 2-macroglobulin receptors on the surface of Swiss 3T3 cells was measured by using fluorescence photobleaching recovery. The two-dimensional effective diffusion coefficient of R-alpha 2M receptors was approximately 8 X 10(-10) cm2 s-1, a value close to that previously obtained for insulin and epidermal growth factor receptors. Degradation of R-alpha 2M by the cells was followed by using the loss of fluorescence from the 185000-dalton band in sodium dodecyl sulfate--polyacrylamide gels. Rhodamine fluorescence was detected in the gels by using a microscope fluorescence spectrophotometer. NRK cells degraded alpha 2M to low molecular weight fragments with a t 1/2 of 15 min. Swiss 3T3 cells degraded about 75% of the alpha 2M with a t 1/2 of 1 h. The remaining 25% remained as the intact 185000-dalton peptide after 24 h. No significant accumulation of large breakdown products was observed in Swiss 3T3 or NRK cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170323     DOI: 10.1021/bi00521a041

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Isolation of active subforms of alpha 2-macroglobulin.

Authors:  J F Chlebowski; K Williams
Journal:  Biochem J       Date:  1985-07-01       Impact factor: 3.857

2.  Localization of basic residues required for receptor binding to the single alpha-helix of the receptor binding domain of human alpha2-macroglobulin.

Authors:  W Huang; K Dolmer; X Liao; P G Gettins
Journal:  Protein Sci       Date:  1998-12       Impact factor: 6.725

3.  Detection of alpha 2-macroglobulin, alpha 1-protease inhibitor, and neutral protease-antiprotease complexes within liver granulomas of Schistosoma mansoni-infected mice.

Authors:  J L Truden; D L Boros
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

Review 4.  Transglutaminase and receptor-mediated endocytosis in macrophages and cultured fibroblasts.

Authors:  P J Davies; M P Murtaugh
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

Review 5.  Lateral motion of membrane proteins and biological function.

Authors:  D Axelrod
Journal:  J Membr Biol       Date:  1983       Impact factor: 1.843

6.  Antigen delivery by alpha(2)-macroglobulin enhances the cytotoxic T lymphocyte response.

Authors:  Edith V Bowers; Jeffrey J Horvath; Jennifer E Bond; George J Cianciolo; Salvatore V Pizzo
Journal:  J Leukoc Biol       Date:  2009-08-03       Impact factor: 4.962

7.  Immunofluorescent localization of four serum proteinase inhibitors in normal rat liver.

Authors:  W Stauber; V Fritz; F Esnard; F Gauthier
Journal:  Histochem J       Date:  1983-02

8.  The human alpha 2-macroglobulin receptor: identification of a 420-kD cell surface glycoprotein specific for the activated conformation of alpha 2-macroglobulin.

Authors:  J D Ashcom; S E Tiller; K Dickerson; J L Cravens; W S Argraves; D K Strickland
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

9.  Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts.

Authors:  F R Maxfield
Journal:  J Cell Biol       Date:  1982-11       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.